These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1032 related items for PubMed ID: 9815796

  • 1. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK, Schwartz DP, Mann E, Chen H, Tsai J, Chu L, Taylorson L, Longhi M, Meredith S, Germain L, Jacobs JS, Tang C, Ullrich A, Berens ME, Hersh E, McMahon G, Hirth KP, Powell TJ.
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC, Keiser JA.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [Abstract] [Full Text] [Related]

  • 3. Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts.
    Strawn LM, Kabbinavar F, Schwartz DP, Mann E, Shawver LK, Slamon DJ, Cherrington JM.
    Clin Cancer Res; 2000 Jul; 6(7):2931-40. PubMed ID: 10914743
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE, Pang L, Huber LJ, Chen H, Tsai JM, Hirth P, Gazit A, Levitzki A, McMahon G.
    J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
    [Abstract] [Full Text] [Related]

  • 5. Differential responses of EGFR-/AGT-expressing cells to the "combi-triazene" SMA41.
    Matheson SL, McNamee JP, Jean-Claude BJ.
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):11-20. PubMed ID: 12497201
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice.
    Kim SJ, Uehara H, Yazici S, Langley RR, He J, Tsan R, Fan D, Killion JJ, Fidler IJ.
    Cancer Res; 2004 Jun 15; 64(12):4201-8. PubMed ID: 15205332
    [Abstract] [Full Text] [Related]

  • 7. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
    Panek RL, Lu GH, Klutchko SR, Batley BL, Dahring TK, Hamby JM, Hallak H, Doherty AM, Keiser JA.
    J Pharmacol Exp Ther; 1997 Dec 15; 283(3):1433-44. PubMed ID: 9400019
    [Abstract] [Full Text] [Related]

  • 8. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
    Klutchko SR, Hamby JM, Boschelli DH, Wu Z, Kraker AJ, Amar AM, Hartl BG, Shen C, Klohs WD, Steinkampf RW, Driscoll DL, Nelson JM, Elliott WL, Roberts BJ, Stoner CL, Vincent PW, Dykes DJ, Panek RL, Lu GH, Major TC, Dahring TK, Hallak H, Bradford LA, Showalter HD, Doherty AM.
    J Med Chem; 1998 Aug 13; 41(17):3276-92. PubMed ID: 9703473
    [Abstract] [Full Text] [Related]

  • 9. K252a inhibits proliferation of glioma cells by blocking platelet-derived growth factor signal transduction.
    Chin LS, Murray SF, Zitnay KM, Rami B.
    Clin Cancer Res; 1997 May 13; 3(5):771-6. PubMed ID: 9815748
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of PDGF-induced phosphoinositide-turnover by glucopiericidin A.
    Ahn SC, Kim BY, Park CS, Lee HS, Suh PG, Ryu SH, Rho HM, Rhee JS, Mheen TI, Ahn JS.
    Biochem Mol Biol Int; 1995 Sep 13; 37(1):125-32. PubMed ID: 8653074
    [Abstract] [Full Text] [Related]

  • 11. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, Meyer T, Tang C, Wartmann M, Wood J, Caravatti G.
    Cancer Res; 2004 Jul 15; 64(14):4931-41. PubMed ID: 15256466
    [Abstract] [Full Text] [Related]

  • 12. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
    Huang JS, Nishimura J, Huang SS, Deuel TF.
    J Cell Biochem; 1984 Jul 15; 26(4):205-20. PubMed ID: 6099364
    [Abstract] [Full Text] [Related]

  • 13. Platelet-derived growth factor (PDGF) and glial tumorigenesis.
    Shih AH, Holland EC.
    Cancer Lett; 2006 Feb 08; 232(2):139-47. PubMed ID: 16139423
    [Abstract] [Full Text] [Related]

  • 14. GM1 inhibits early signaling events mediated by PDGF receptor in cultured human glioma cells.
    Farooqui T, Kelley T, Coggeshall KM, Rampersaud AA, Yates AJ.
    Anticancer Res; 1999 Feb 08; 19(6B):5007-13. PubMed ID: 10697503
    [Abstract] [Full Text] [Related]

  • 15. Activation of signal transduction pathways protects quiescent Balb/c-3T3 fibroblasts against death due to serum deprivation.
    Tamm I, Kikuchi T.
    J Cell Physiol; 1991 Jul 08; 148(1):85-95. PubMed ID: 1713593
    [Abstract] [Full Text] [Related]

  • 16. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA, Sullivan CM, Hollenbach SJ, Israel MA, Giese NA.
    Cancer Res; 2002 Jul 01; 62(13):3729-35. PubMed ID: 12097282
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone attenuation of epidermal growth factor-induced mitogenesis.
    Wiepz GJ, Houtman JC, Cha D, Bertics PJ.
    J Cell Physiol; 1997 Oct 01; 173(1):44-53. PubMed ID: 9326448
    [Abstract] [Full Text] [Related]

  • 18. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.
    Dabrow MB, Francesco MR, McBrearty FX, Caradonna S.
    Gynecol Oncol; 1998 Oct 01; 71(1):29-37. PubMed ID: 9784315
    [Abstract] [Full Text] [Related]

  • 19. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.
    Mioh H, Chen JK.
    J Cell Physiol; 1989 Jun 01; 139(3):509-16. PubMed ID: 2472412
    [Abstract] [Full Text] [Related]

  • 20. Platelet-derived growth factor in human glioma.
    Westermark B, Heldin CH, Nistér M.
    Glia; 1995 Nov 01; 15(3):257-63. PubMed ID: 8586462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.